Patients on this protocol who also use metabolic support agents like Metformin should note that both agents activate AMPK, and physician oversight is warranted to avoid compounding effects on blood glucose that could theoretically cause hypoglycemia in susceptible individuals, though this has not been reported clinically with MOTS-c at standard doses
Men with stubborn weight or slow metabolism: The combination of testosterone, GH-releasing peptides, and potentially tesamorelin can break through weight loss plateaus
Weeks 1-4: 0.10mL 10 units/week Weeks 5-8: 0.20mL 20 units/week Weeks 9-12: 0.30mL 30 units/week After finishing a vial, patients take the 2-month tolerance break.
Recent research identified a cystatin, CsCPI1, a cysteine proteinase inhibitor from the tea plant Camellia sinensis (L.)
Digestive issues: Loss of appetite, weight loss, constipation, or diarrhea